Want to see AU:EPN full AI Analyst Report?
EPN Stock Chart & Stats
AU$0.02
AU$0.00(0.00%)
At close: 4:00 PM EDT
AU$0.02
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.02 - AU$0.04
Previous CloseN/A
Volume347.89K
Average Volume (3M)258.48K
Market Cap
AU$11.28M
Enterprise ValueAU$15.96
Total Cash (Recent Filing)AU$1.29M
Total Debt (Recent Filing)AU$8.69M
Price to Earnings (P/E)―
Beta-0.49
Next Earnings
Feb 26, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding389,104,000
10 Day Avg. Volume267,465
30 Day Avg. Volume258,476
Financial Highlights & Ratios
PEG Ratio0.16
Price to Book (P/B)6.55
Price to Sales (P/S)1.33
P/FCF Ratio-3.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue ReboundThe sharp 2025 revenue rebound indicates renewed commercial traction and provides a larger base from which management can pursue operating improvements. If retained over the next several quarters, stronger revenue scale could support better fixed-cost absorption and improve the path toward profitability.
Improving Loss TrendThe reduction in losses shows that performance has moved in a better direction despite the company remaining unprofitable. Continued improvement could indicate progress in the turnaround, potentially narrowing the gap between revenue growth and sustainable operating earnings over the medium term.
Positive Gross ProfitPositive gross profit demonstrates that 2025 revenue contributed economically before operating costs, giving the business a foundation for further efficiency gains. Converting that gross profitability into positive operating income remains necessary, but the underlying sales mix is not wholly uneconomic.
Bears Say
Persistent UnprofitabilityPersistent operating and net losses mean the company has not yet demonstrated sustainable earnings power, even after the revenue rebound. Continued losses can restrict reinvestment capacity and make future performance dependent on successful execution of the turnaround rather than established profitability.
Negative Cash GenerationConsistently negative operating and free cash flow shows that the business is still consuming cash to operate rather than funding itself internally. This weakens financial resilience, limits flexibility to invest in growth, and increases the importance of external funding or available balance-sheet capacity.
Materially Higher LeverageThe sharp increase in leverage and shrinking equity base materially reduce financial flexibility while the company remains loss-making. Higher debt relative to equity can increase financing pressure and leave fewer resources available to absorb setbacks or support the business through its turnaround.
Epsilon Healthcare Limited News
EPN FAQ
What was Epsilon Healthcare Limited’s price range in the past 12 months?
Epsilon Healthcare Limited lowest share price was AU$0.02 and its highest was AU$0.04 in the past 12 months.
What is Epsilon Healthcare Limited’s market cap?
Epsilon Healthcare Limited’s market cap is AU$11.28M.
When is Epsilon Healthcare Limited’s upcoming earnings report date?
Epsilon Healthcare Limited’s upcoming earnings report date is Feb 26, 2027 which is in 158 days.
How were Epsilon Healthcare Limited’s earnings last quarter?
Epsilon Healthcare Limited released its earnings results on Aug 31, 2026. The company reported -AU$0.002 earnings per share for the quarter.
Is Epsilon Healthcare Limited overvalued?
According to Wall Street analysts Epsilon Healthcare Limited’s price is currently Overvalued.
Does Epsilon Healthcare Limited pay dividends?
Epsilon Healthcare Limited does not currently pay dividends.
What is Epsilon Healthcare Limited’s EPS estimate?
Epsilon Healthcare Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Epsilon Healthcare Limited have?
Epsilon Healthcare Limited has 389,104,000 shares outstanding.
What happened to Epsilon Healthcare Limited’s price movement after its last earnings report?
Epsilon Healthcare Limited reported an EPS of -AU$0.002 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Epsilon Healthcare Limited?
Currently, no hedge funds are holding shares in AU:EPN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Epsilon Healthcare Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Insider Transactions
Bought Shares
Worth AU$68.8K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
121.58%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Epsilon Healthcare Limited
Epsilon Healthcare Limited operates as an Australian-based healthcare and pharmaceutical firm, with significant operations also extending into Canada. Established in 2016 and headquartered in Sydney, the company specializes in several areas: manufacturing and distributing a range of hydroponic supplies, including equipment, materials, and vital nutrients; developing and providing medicinal cannabis products; and offering comprehensive, ready-to-implement solutions for cannabis cultivation. The company officially rebranded from THC Global Group Limited to Epsilon Healthcare Limited in February 2021.
Technical Analysis
Vita Life Sciences Limited
―
Little Green Pharma Ltd.
―
Medical Developments International Limited
―
Althea Group Holdings Ltd.
―
IDT Australia Limited
―